Skip to main content
. 2024 Apr 16;39(2):206–221. doi: 10.3803/EnM.2024.1940

Fig. 2.

Fig. 2.

Structures of formulations of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and glucose-dependent insulinotropic polypeptide/ GLP-1RA. Modified from Tschop et al. [36]. GIP, glucose-dependent insulinotropic polypeptide.